Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Bonde

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Ugeskrift for Laeger|February 12, 2010
[Necrotizing fasciitis]Anders Peter Skovsen, Jan Bonde, Jakob Steen Andersen, et al.
Critical Care (London, England)|February 21, 2004
Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairmentDes Breen, Alexander Wilmer, Andrew Bodenham, et al.
Immunobiology|May 28, 2013
Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohortsBrian Kornblit, Dorthe Hellemann, Lea Munthe-Fog, et al.
Human Molecular Genetics|September 18, 2007
Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patientsDorthe Hellemann, Anders Larsson, Hans O Madsen, et al.
Acta Anaesthesiologica Scandinavica|February 2, 2021
Training non-intensivist doctors to work with COVID-19 patients in intensive care unitsMorten Engberg, Jan Bonde, Sigurdur T Sigurdsson, et al.
Ugeskrift for Laeger|January 9, 2009
["Who does watch the head watcher"--who can and will watch the experts treatment?]Jan Bonde, Lise Fonsmark, Tom H Jensen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Ugeskrift for Laeger|February 12, 2010
[Necrotizing fasciitis]Anders Peter Skovsen, Jan Bonde, Jakob Steen Andersen, et al.
Critical Care (London, England)|February 21, 2004
Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairmentDes Breen, Alexander Wilmer, Andrew Bodenham, et al.
Immunobiology|May 28, 2013
Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohortsBrian Kornblit, Dorthe Hellemann, Lea Munthe-Fog, et al.
Human Molecular Genetics|September 18, 2007
Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patientsDorthe Hellemann, Anders Larsson, Hans O Madsen, et al.
Acta Anaesthesiologica Scandinavica|February 2, 2021
Training non-intensivist doctors to work with COVID-19 patients in intensive care unitsMorten Engberg, Jan Bonde, Sigurdur T Sigurdsson, et al.
Ugeskrift for Laeger|January 9, 2009
["Who does watch the head watcher"--who can and will watch the experts treatment?]Jan Bonde, Lise Fonsmark, Tom H Jensen, et al.
Pageof 2